COLLEGIUM PHARMACEUTICAL, INC (COLL)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Product revenues, net | 188,000 | 177,757 | 159,301 | 145,276 |
| Intangible asset amortization and impairment | 55,473 | 55,473 | 40,801 | 34,515 |
| Cost of product revenues (excluding intangible asset amortization) | 24,143 | 24,960 | 21,706 | 19,955 |
| Total cost of product revenues | 79,616 | 80,433 | 62,507 | 54,470 |
| Gross profit | 108,384 | 97,324 | 96,794 | 90,806 |
| Selling, general and administrative | 73,637 | 76,423 | 61,955 | 43,335 |
| Gain on fair value remeasurement of contingent consideration | -358 | -786 | - | - |
| Total operating expenses | 73,279 | 75,637 | 61,955 | 43,335 |
| Income from operations | 35,105 | 21,687 | 34,839 | 47,471 |
| Interest income | 2,383 | 2,225 | - | - |
| Interest expense | 20,463 | 20,790 | 18,394 | 15,587 |
| Gains (losses) on extinguishment of debt | - | - | -4,145 | -7,184 |
| Investment income, net | - | - | 3,280 | 4,397 |
| Income before income taxes | 17,025 | 3,122 | 15,580 | 29,097 |
| Provision for income taxes | 5,042 | 705 | 6,245 | 9,491 |
| Net income | 11,983 | 2,417 | 9,335 | 19,606 |
| Earnings per share, basic | 0.38 | 0.08 | 0.29 | 0.6 |
| Earnings per share, diluted | 0.34 | 0.07 | 0.27 | 0.52 |
| Weighted average number of shares outstanding, basic | 31,810,612 | 31,793,739 | 32,259,468 | 32,433,025 |
| Weighted average number of shares outstanding, diluted | 39,075,703 | 32,840,153 | 40,163,266 | 40,383,694 |